Houston Wyatt - Search Results

Year	Number of Results
2019	3
2020	2
2022	1
2024	0

1

An Integrated Health-System Specialty Pharmacy Model for Coordinating Transitions of Care: Specialty Medication Challenges and Specialty Pharmacist Opportunities.

Zuckerman AD, Carver A, Cooper K, Markley B, Mitchell A, Reynolds VW, Saknini M, Wyatt H, Kelley T. Zuckerman AD, et al. Among authors: wyatt h. Pharmacy (Basel). 2019 Dec 3;7(4):163. doi: 10.3390/pharmacy7040163. Pharmacy (Basel). 2019. PMID: 31816884 Free PMC article. Review.

2

Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions.

Wyatt H, Zuckerman AD, Hughes ME, Arnall J, Miller R. Wyatt H, et al. J Oncol Pharm Pract. 2022 Apr;28(3):627-634. doi: 10.1177/10781552211072467. Epub 2022 Jan 17. J Oncol Pharm Pract. 2022. PMID: 35037778

3

Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents.

Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Harrell S, Rubinstein SM, Hall R, Wyatt H, Piazza G. Cornell RF, et al. Among authors: wyatt h. Br J Haematol. 2020 Aug;190(4):555-561. doi: 10.1111/bjh.16653. Epub 2020 Apr 21. Br J Haematol. 2020. PMID: 32314352 Free article. Clinical Trial.

4

Ivosidenib: IDH1 Inhibitor for the Treatment of Acute Myeloid Leukemia.

Merchant SL, Culos K, Wyatt H. Merchant SL, et al. Among authors: wyatt h. J Adv Pract Oncol. 2019 Jul;10(5):494-500. doi: 10.6004/jadpro.2019.10.5.7. Epub 2019 Jul 1. J Adv Pract Oncol. 2019. PMID: 33457062 Free PMC article.

5

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy.

Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Patton D, Harrell S, Hall R, Wyatt H, Piazza G. Cornell RF, et al. Among authors: wyatt h. Front Oncol. 2019 Feb 26;9:45. doi: 10.3389/fonc.2019.00045. eCollection 2019. Front Oncol. 2019. PMID: 30873378 Free PMC article.

6

The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.

Byrne M, Danielson N, Sengsayadeth S, Rasche A, Culos K, Gatwood K, Wyatt H, Chinratanalab W, Dholaria B, Ferrell PB, Fogo K, Goodman S, Jagasia M, Jayani R, Kassim A, Mohan SR, Savani BN, Strickland SA, Engelhardt BG, Savona M. Byrne M, et al. Among authors: wyatt h. Am J Hematol. 2020 Sep;95(9):1006-1014. doi: 10.1002/ajh.25859. Epub 2020 Jun 15. Am J Hematol. 2020. PMID: 32390196 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year